Logsdon, Craig D.

RAGE and RAGE ligands in cancer

Logsdon, C., Fuentes, M., Huang, E., & Arumugam, T. (2007) · Current Molecular Medicine

Advanced Glycation End Products researchGalectins and Cancer Biology

Cited by 209

Ras Activity Levels Control the Development of Pancreatic Diseases

Ji, B., Tsou, L., Wang, H., Gaiser, S., Chang, D. Z., Daniluk, J., Bi, Y., Grote, T., Longnecker, D. S., & Logsdon, C. D. (2009) · Gastroenterology

Pancreatic and Hepatic Oncology ResearchProtein Kinase Regulation and GTPase Signaling

Cited by 194

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models

Arumugam, T., Ramachandran, V., & Logsdon, C. D. (2006) · JNCI: Journal of the National Cancer Institute

S100 Proteins and AnnexinsAdvanced Glycation End Products research

Cited by 159

S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis

Arumugam, T., Ramachandran, V., Gomez, S. B., Schmidt, A. M., & Logsdon, C. D. (2012) · Clinical Cancer Research

Advanced Glycation End Products researchS100 Proteins and Annexins

Cited by 153

S100P: a novel therapeutic target for cancer

Arumugam, T., & Logsdon, C. D. (2011) · Amino Acids

S100 Proteins and AnnexinsAdvanced Glycation End Products research

Cited by 125